Skip to main content
. 2020 Dec 23;23(7):1100–1112. doi: 10.1093/neuonc/noaa298

Fig. 1.

Fig. 1

Survival correlates of the EANO ESMO classification. Survival stratified by level of evidence of the LM diagnosis (confirmed, probable, possible) (A), by presence vs absence of tumor cells in the CSF (B), by pattern of neuroimaging (C), by absence vs presence of nodular disease in type I (D) and type II (E) patients, and by the most common primary tumor (F).